Clinical Report: Serum Vitamin B12 Levels and Diabetic Retinopathy in T2DM
Overview
This study investigates the association between serum vitamin B12 levels and diabetic retinopathy (DR) in adults with type 2 diabetes mellitus (T2DM).
Background
Diabetic retinopathy is a leading cause of blindness among diabetic patients, and understanding its risk factors is crucial for prevention and management. Vitamin B12 plays a significant role in various metabolic processes, and its deficiency has been linked to neurological and vascular complications in diabetes. The relationship between vitamin B12 levels and DR remains inconsistent across studies, warranting further investigation.
Data Highlights
Vitamin B12 Increase (μmol/L)
Odds Ratio (OR)
95% Confidence Interval (CI)
p-value
100
1.49
1.12–1.99
0.0067
Highest tertile (≥398)
11.83
1.79–78.19
0.0103
Key Findings
Each 100 μmol/L increase in vitamin B12 is associated with a higher risk of DR (OR = 1.49).
Participants in the highest tertile of vitamin B12 (≥398 μmol/L) have a significantly elevated risk of DR (OR = 11.83).
The association between vitamin B12 and DR is linear, as indicated by generalized additive models.
No significant interactions were found across prespecified subgroups (all P for interaction >0.05).
Higher vitamin B12 levels were independently associated with greater DR prevalence in adults with T2DM.
Clinical Implications
Further research is needed to clarify the mechanisms underlying the association between serum vitamin B12 levels and diabetic retinopathy.
Conclusion
The study highlights a significant association between elevated serum vitamin B12 levels and increased prevalence of diabetic retinopathy in individuals with type 2 diabetes.
